Impact of COVID‐19 on percutaneous coronary intervention utilization and mortality in New York

COVID‐19 has disrupted the care of all patients, and little is known about its impact on the utilization and short‐term mortality of percutaneous coronary intervention (PCI) patients, particularly nonemergency patients.

[1]  H. Gurm,et al.  Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan , 2022, PloS one.

[2]  K. Wood,et al.  Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. , 2021, JAMA.

[3]  Brian C. Case,et al.  Initial Findings From the North American COVID-19 Myocardial Infarction Registry , 2021, Journal of the American College of Cardiology.

[4]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[5]  E. Hannan,et al.  Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York , 2020, The American Journal of Cardiology.

[6]  Massimo Siviglia,et al.  Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI , 2020, Journal of the American College of Cardiology.

[7]  B. Billah,et al.  Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis , 2020, American journal of respiratory and critical care medicine.

[8]  N. Curzen,et al.  Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction , 2020, Heart.

[9]  D. Xiang,et al.  Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China , 2020, Journal of the American College of Cardiology.

[10]  K. Spinelli,et al.  Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic. , 2020, JAMA cardiology.

[11]  A. Baumbach,et al.  High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction , 2020, Journal of the American College of Cardiology.

[12]  T. Kiernan,et al.  COVID-19 and STEMI: A snapshot analysis of presentation patterns during a pandemic , 2020, IJC Heart & Vasculature.

[13]  Alon Yarkoni,et al.  Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York , 2020, American Heart Journal.

[14]  Scott D. Solomon,et al.  Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[15]  R. de Caterina,et al.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era , 2020, European heart journal.

[16]  O. Rodriguez-Leor,et al.  Impact of the COVID-19 pandemic on interventional cardiology activity in Spain , 2020, REC: interventional cardiology (English Edition).

[17]  F. Fedele,et al.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy , 2020, The New England journal of medicine.

[18]  A. Bauer,et al.  Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage , 2020, European heart journal.

[19]  C. Schmidt,et al.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[20]  C. Siu,et al.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China , 2020, Circulation. Cardiovascular quality and outcomes.

[21]  B. Ibáñez,et al.  In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients , 2021, EuroIntervention.

[22]  E. Hannan,et al.  Out-of-hospital deaths within 30 days following hospitalization where percutaneous coronary intervention was performed. , 2012, The American journal of cardiology.